DE60115631D1 - Halbfester verabreichungsträger und arzneimittel - Google Patents

Halbfester verabreichungsträger und arzneimittel

Info

Publication number
DE60115631D1
DE60115631D1 DE60115631T DE60115631T DE60115631D1 DE 60115631 D1 DE60115631 D1 DE 60115631D1 DE 60115631 T DE60115631 T DE 60115631T DE 60115631 T DE60115631 T DE 60115631T DE 60115631 D1 DE60115631 D1 DE 60115631D1
Authority
DE
Germany
Prior art keywords
medicinal products
administrative
sensitive
semi
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60115631T
Other languages
English (en)
Other versions
DE60115631T2 (de
Inventor
Y Ng
Hui-Rong Shen
Jorge Heller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heron Therapeutics LLC
Original Assignee
AP Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AP Pharma Inc filed Critical AP Pharma Inc
Publication of DE60115631D1 publication Critical patent/DE60115631D1/de
Application granted granted Critical
Publication of DE60115631T2 publication Critical patent/DE60115631T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60115631T 2000-05-11 2001-05-11 Halbfester verabreichungsträger und arzneimittel Expired - Lifetime DE60115631T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56971700A 2000-05-11 2000-05-11
US569717 2000-05-11
PCT/US2001/015409 WO2001085139A2 (en) 2000-05-11 2001-05-11 Semi-solid delivery vehicle and pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE60115631D1 true DE60115631D1 (de) 2006-01-12
DE60115631T2 DE60115631T2 (de) 2006-08-10

Family

ID=24276565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115631T Expired - Lifetime DE60115631T2 (de) 2000-05-11 2001-05-11 Halbfester verabreichungsträger und arzneimittel

Country Status (8)

Country Link
EP (1) EP1280558B1 (de)
AT (1) ATE311904T1 (de)
AU (1) AU2001261516A1 (de)
CA (1) CA2445638C (de)
DE (1) DE60115631T2 (de)
DK (1) DK1280558T3 (de)
ES (1) ES2253381T3 (de)
WO (1) WO2001085139A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20020176844A1 (en) * 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
WO2002092661A1 (en) * 2001-05-11 2002-11-21 Ap Pharma, Inc. Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7045589B2 (en) 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
EP2044142A2 (de) 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester)polymere sowie herstellungs- und verwendungsverfahren dafür
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
US8475823B2 (en) 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
CA2906666C (en) * 2013-03-15 2019-12-24 Heron Therapeutics, Inc. Compositions of a polyorthoester and an aprotic solvent
US10980886B2 (en) * 2014-04-21 2021-04-20 Heron Therapeutics, Inc. Compositions of a polyorthoester and an organic acid excipient
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
WO2022152835A1 (en) * 2021-01-18 2022-07-21 Evonik Operations Gmbh High molecular weight triethylene-glycol polyorthoester iv (teg-poe iv) polymers and compositions for drug delivery and medical implants applications
WO2023137659A1 (zh) * 2022-01-20 2023-07-27 南京泛太化工医药研究所 一种具有酸敏感降解、温敏性质的系列聚合物及其载药组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99989A (pt) * 1991-01-09 1994-05-31 Alza Corp Dispositivos biodegradaveis e composicoes para libertacao difusivel de agentes
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US5939453A (en) * 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers

Also Published As

Publication number Publication date
CA2445638C (en) 2010-02-09
AU2001261516A1 (en) 2001-11-20
WO2001085139A2 (en) 2001-11-15
EP1280558A2 (de) 2003-02-05
EP1280558B1 (de) 2005-12-07
WO2001085139A3 (en) 2002-04-18
DK1280558T3 (da) 2005-12-27
ES2253381T3 (es) 2006-06-01
ATE311904T1 (de) 2005-12-15
DE60115631T2 (de) 2006-08-10
CA2445638A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
TW200616650A (en) Semi-solid delivery vehicle and pharmaceutical compositions
DE60115631D1 (de) Halbfester verabreichungsträger und arzneimittel
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE60021059D1 (de) Hydrogelpartikel formulierungen
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
EE04850B1 (et) Pürimidiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutamiseks HIV nakku
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ATE450252T1 (de) Arzneimittel-mikroteilchen
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
WO2002045752A3 (en) Dermal anti-inflammatory composition
ATE292453T1 (de) Antivirale arznei
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
BR0109747A (pt) Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática
BR0007452A (pt) Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação
ATE356637T1 (de) Supramolekulare komplexe enthaltende arzneimittel
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
NO323466B1 (no) Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater
WO2002000208A3 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
SE0001916D0 (sv) Novel formulation
ATE177638T1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
SE9902936D0 (sv) Pharmaceutical compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition